GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Infant Bacterial Therapeutics AB (STU:9IB) » Definitions » Dividend Yield %

Infant Bacterial Therapeutics AB (STU:9IB) Dividend Yield % : 0.00% (As of Mar. 13, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Infant Bacterial Therapeutics AB Dividend Yield %?

As of today (2025-03-13), the Trailing Annual Dividend Yield of Infant Bacterial Therapeutics AB is 0.00%.

The historical rank and industry rank for Infant Bacterial Therapeutics AB's Dividend Yield % or its related term are showing as below:

STU:9IB's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.43
* Ranked among companies with meaningful Dividend Yield % only.

Infant Bacterial Therapeutics AB's Dividend Payout Ratio for the three months ended in Dec. 2024 was 0.00.

As of today (2025-03-13), the Forward Dividend Yield % of Infant Bacterial Therapeutics AB is 0.00%.

Infant Bacterial Therapeutics AB's Dividends per Share for the three months ended in Dec. 2024 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Infant Bacterial Therapeutics AB Dividend Yield % Historical Data

The historical data trend for Infant Bacterial Therapeutics AB's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Infant Bacterial Therapeutics AB Dividend Yield % Chart

Infant Bacterial Therapeutics AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Infant Bacterial Therapeutics AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Infant Bacterial Therapeutics AB's Dividend Yield %

For the Biotechnology subindustry, Infant Bacterial Therapeutics AB's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Infant Bacterial Therapeutics AB's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Infant Bacterial Therapeutics AB's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Infant Bacterial Therapeutics AB's Dividend Yield % falls into.



Infant Bacterial Therapeutics AB Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Infant Bacterial Therapeutics AB  (STU:9IB) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Infant Bacterial Therapeutics AB Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Infant Bacterial Therapeutics AB's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Infant Bacterial Therapeutics AB Business Description

Traded in Other Exchanges
Address
Bryggargatan 10, Stockholm, SWE, 111 21
Infant Bacterial Therapeutics AB is a pharmaceutical company. Its purpose is to develop and commercialize drugs for diseases affecting premature babies. Its focus is on the drug candidate IBP-9414, whose development program is designed to show a reduced incidence of necrotizing enterocolitis (NEC) and improved gastrointestinal function (SFT) when treated with IBP-9414's active substance Lactobacillus reuteri bacterial strain naturally found in human breast milk. Its portfolio also includes additional drug candidates, IBP-1016, IBP-1118 and IBP-1122. IBP1016, for the treatment of gastroschisis, is a life-threatening and rare disorder in which children are born with externalized gastrointestinal organs.

Infant Bacterial Therapeutics AB Headlines

No Headlines